EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis

Ting-Jui Hsu iD, Rong-Hong Hsieh, Chin-Huan Huang, Chih-Shou Chen iD, Wei-Yu Lin, Yun-Ching Huang, Jian-Hui Lin, Kuo-Tsai Huang, Yu-Liang Liu, Hui-Ming Tsai iD, Dong-Ru Ho iD

Nutrients · 2024

DOI: 10.3390/nu16234116 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nutrients, 2024. Verfasst von Ting-Jui Hsu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan. Hauptthemen laut MEDLINE: Dietary Supplements, Dysmenorrhea, Zinc. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Primary dysmenorrhea (PD) is a common condition affecting up to 90% of menstruating women, which often results in significant pain without an underlying pathology. Zinc, recognized for its anti-inflammatory and antioxidant effects through inhibiting prostaglandin production and superoxide dismutase 1 (SOD1) upregulation, alleviates menstrual pain by preventing uterine spasms and enhancing microcirculation in the endometrium, suggesting its potential as an alternative treatment for primary dysmenorrhea. The goal of this systematic review and meta-analysis was to assess the efficacy and safety of zinc supplementation in reducing pain severity among women with PD and to explore the influence of dosage and treatment duration.

Methods

Following the PRISMA 2020 guidelines, we conducted an extensive search across databases such as PubMed, Embase, Cochrane Library, Web of Science, and Google Scholar, up to May 2024. Randomized controlled trials assessing the effects of zinc supplementation on pain severity in women with PD were included. Pain severity was evaluated with established tools, such as the Visual Analog Scale (VAS). Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB2) tool. Two reviewers independently performed the data extraction, and a random-effects model was used for meta-analysis. Meta-regressions were conducted to examine the influence of zinc dosage and treatment duration on pain reduction. Adverse events were also analyzed.

Results

Six RCTs involving 739 participants met the inclusion criteria. Zinc supplementation significantly reduced pain severity compared to placebo (Hedges’s g = −1.541; 95% CI: −2.268 to −0.814; p < 0.001), representing a clinically meaningful reduction in pain. Meta-regression indicated that longer treatment durations (≥8 weeks) were associated with greater pain reduction (p = 0.003). While higher zinc doses provided additional pain relief, the incremental benefit per additional milligram was modest (regression coefficient = −0.02 per mg; p = 0.005). Adverse event rates did not differ significantly between the zinc and placebo groups (odds ratio = 2.54; 95% CI: 0.78 to 8.26; p = 0.122), suggesting good tolerability.

Conclusions

Zinc supplementation is an effective and well-tolerated option for reducing pain severity in women with primary dysmenorrhea. Doses as low as 7 mg/day of elemental zinc are sufficient to achieve significant pain relief, with longer durations (≥8 weeks) enhancing efficacy. The favorable safety profile and ease of use support the consideration of zinc supplementation as a practical approach to managing primary dysmenorrhea.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsDysmenorrheaZincFemaleHumansPain MeasurementRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

anti-inflammatorymenstrual painmeta-analysisnutritional supplementspain reliefprimary dysmenorrhearandomized controlled trialswomen’s healthzinc supplementation

Substanzen

Zinc

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
  • School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
  • Research Center of Nutritional Medicine, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
  • Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Nutrition Therapy, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 622401, Taiwan.
  • School of Medicine, National Cheng Kung University, Tainan City 701401, Taiwan.

ORCID-Profile: Ting-Jui Hsu, Chih-Shou Chen, Hui-Ming Tsai, Dong-Ru Ho

Zitieren

APA

Hsu, T. J., Hsieh, R. H., Huang, C. H., Chen, C. S., Lin, W. Y., Huang, Y. C., Lin, J. H., Huang, K. T., Liu, Y. L., Tsai, H. M., & Ho, D. R. (2024). Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis. Nutrients. https://doi.org/10.3390/nu16234116

Vancouver

Hsu TJ, Hsieh RH, Huang CH, Chen CS, Lin WY, Huang YC, et al. Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis. Nutrients. 2024. doi:10.3390/nu16234116

BibTeX
@article{Hsu2024,
  author = {Hsu, Ting-Jui and Hsieh, Rong-Hong and Huang, Chin-Huan and Chen, Chih-Shou and Lin, Wei-Yu and Huang, Yun-Ching and Lin, Jian-Hui and Huang, Kuo-Tsai and Liu, Yu-Liang and Tsai, Hui-Ming and Ho, Dong-Ru},
  title = {Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16234116}
}
Kostenlos starten →